Most cited papers from 1 - Cube (Czechia)

1 - Cube (Czechia)

What are the most cited papers from 1 - Cube (Czechia)?

The most cited paper from 1 - Cube (Czechia) is "Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection" (Joan‐Carles Arce, Anders Nyboe Andersen, Manuel Fernández Sánchez et al., 2014), with 192 citations. Next come "Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles" (43) and "A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol" (26).

Published FieldAccess

Showing 8 of 8 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection Joan‐Carles Arce, Anders Nyboe Andersen, Manuel Fernández Sánchez et al. · Fertility and Sterility Open access	23 Sep 2014	192
2	Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles Manuel Fernández Sánchez, Hana Višňová, Albert A. Yuzpe et al. · Reproductive BioMedicine Online Open access	23 Dec 2018	43
3	A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol Manuel Fernández Sánchez et al. · Human Reproduction Open access	14 Apr 2022	26
4	Follicular and endocrine dose responses according to anti‐Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH ( FE 999049) Ernesto Bosch, Anders Nyboe Andersen, Pedro N. Barri et al. · Clinical Endocrinology Open access	23 Jul 2015	21
5	Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials Georg Griesinger, Christophe Blockeel, Piotr Pierzyński et al. · Human Reproduction	28 Dec 2020	18
6	A placebo-controlled, randomized, double-blind, phase 3 study assessing ongoing pregnancy rates after single oral administration of a novel oxytocin receptor antagonist, nolasiban, prior to single embryo transfer H. Visnova, Herman J. Tournaye, Andrew Humberstone et al. · Fertility and Sterility Open access	Sep 2018	7
7	Situs Judi Online Terbesar Seasia Tenggara Orbit 898jp, Orbit 898jp · Zenodo (CERN European Organization for Nuclear Research) Open access	7 Jul 2026	0
8	Individualization of the starting dose of gonadotropin reduces the overall OHSS risk and the need of preventive interventions: cumulative data over three stimulation cycles M. Fernandez-Sanchez, H. Visnova, A. Albert Yuzpe et al. · Fertility and Sterility Open access	Sep 2018	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.